ROADMIR BIO CO., LTD. – Trademark Portfolio
Entity Type: 03
ROADMIR BIO CO., LTD. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 8 are pending. Notable registered marks include IEONA and GENEAKG. The owner is based in LAS VEGAS, NV.
1810 E SAHARA AVE, SUITE 351
LAS VEGAS, NV 889104
Showing of trademarks Trademarks
Trademark Classifications
ROADMIR BIO CO., LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ROADMIR BIO CO., LTD. have?
ROADMIR BIO CO., LTD. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 pending.
What trademark classes does ROADMIR BIO CO., LTD. file in?
ROADMIR BIO CO., LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ROADMIR BIO CO., LTD.'s most well-known trademarks?
ROADMIR BIO CO., LTD.'s registered trademark portfolio includes well-known marks such as IEONA and GENEAKG. These are among 2 currently registered trademarks in the portfolio.
What is ROADMIR BIO CO., LTD.'s trademark registration success rate?
ROADMIR BIO CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 8 applications are pending review.